摘要
有关脂肪组织的研究调查几十年来关注于其“储存”功能。最新证据揭示脂肪组织作为一个内分泌器官释放一系列称为脂肪因子的介质。脂肪因子的介导功能包括生理和病理作用,如调节能量代谢、免疫反应和血管内平衡以及炎症和代谢疾病(即动脉粥样硬化、糖尿病和代谢综合征概念中的肥胖)。脂肪因子水平失调已被证实是这些潜在疾病的可能共同病理机理。例如,促炎和抗炎脂肪因子之间的不平衡与肥胖、糖尿病和动脉粥样硬化等疾病中的传统危险因素 (血脂异常、高血压、胰岛素抵抗) 呈正相关。脂肪因子介导的生物活性尤其影响内皮功能障碍/激活和斑块内炎症/易损性。本综述的目的是概述脂肪因子在动脉粥样硬化形成中的作用。讨论基础研究中关于脂肪因子诱导的血管和免疫细胞亚群的调控机制和证据。最后,我们将报道与临床试验相矛盾的结果,并试图使我们更好地理解为什么有价值的基础研究结果无法快速应用于人类的动脉粥样硬化的临床试验研究。
关键词: 脂肪因子;脂联素;动脉粥样硬化;瘦素;脂肪组织
图形摘要
Current Drug Targets
Title:The Role of Adipocytokines in Atherogenesis and Atheroprogression
Volume: 16 Issue: 4
Author(s): Federico Carbone, Francois Mach and Fabrizio Montecucco
Affiliation:
关键词: 脂肪因子;脂联素;动脉粥样硬化;瘦素;脂肪组织
摘要: Research investigations on adipose tissue were focused for several decades on its “storage” function. Emerging evidence unveiled adipose tissue as an endocrine organ releasing a several mediators termed as adipokines. Adipokine-mediated functions include both physiological and pathophysiological roles such as regulation of energy metabolism, immune response and vascular homeostasis, as well as inflammatory and metabolic diseases (i.e. atherogenesis, diabetes and obesity clustered in the concept of metabolic syndrome). A dysregulation of adipokine levels has been also suggested as a potential common mechanism underlying these disorders. For instance, an unbalance between pro- and anti-inflammatory adipokines was positively associated with traditional risk factors (dyslipidaemia, hypertension, insulin resistance) in obesity, diabetes and atherogenesis. Adipokine-mediated activities particularly affected endothelial dysfunction/activation and intraplaque inflammation/vulnerability. The purpose of this narrative review is to provide an overview on the role of adipokines in atherogenesis. Evidence from basic research studies about adipokine-induced regulation of vascular and immune cell subsets will be discussed. Finally, conflicting results from clinical trials we be reported, with an attempt to better understand the reason why promising basic research results did not allow a speedy “into human” translation for clinical management of atherogenesis.
Export Options
About this article
Cite this article as:
Federico Carbone, Francois Mach and Fabrizio Montecucco , The Role of Adipocytokines in Atherogenesis and Atheroprogression, Current Drug Targets 2015; 16 (4) . https://dx.doi.org/10.2174/1389450115666141109213439
DOI https://dx.doi.org/10.2174/1389450115666141109213439 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Related Journals
Related Books
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Cardiovascular Disease in the Setting of Human Immunodeficiency Virus Infection
Current Cardiology Reviews Efalizumab
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry Analysis of QTc Interval during Levofloxacin Prescription in Cardiac Patients with Pneumonia
Current Drug Safety Reprogrammed Metabolism of Cancer Cells as a Potential Therapeutic Target
Current Pharmaceutical Design Tissue Factor/Factor FVII Complex Inhibitors in Cardiovascular Disease. Are Things Going Well?
Current Cardiology Reviews Pharmacological and Lifestyle Factors Modulating Serum Paraoxonase-1 Activity
Mini-Reviews in Medicinal Chemistry Brain Excitatory/Inhibitory Circuits Cross-Talking with Chromogranin A During Hypertensive and Hibernating States
Current Medicinal Chemistry Propionate: Hypophagic Effects Observed in Animal Models Might be Transposed to the Human Obesity Management
Current Nutrition & Food Science Single Nucleotide Polymorphism and Serum Levels of VEGFR2 are Associated With Age Related Macular Degeneration
Current Neurovascular Research Health Benefits of Honey: Implications for Treating Cardiovascular Diseases
Current Nutrition & Food Science Gauging Reactive Metabolites in Drug-Induced Toxicity
Current Medicinal Chemistry Liver X Receptors: Potential Novel Targets in Cardiovascular Diseases
Current Drug Targets - Cardiovascular & Hematological Disorders Strategies to Tackle Early Low Flow States in the Extremely Preterm Infant
Current Pediatric Reviews Podocytes as a Target of Insulin
Current Diabetes Reviews The C-Reactive Protein Levels in Left Ventricular Dysfunction of Different Etiology
Inflammation & Allergy - Drug Targets (Discontinued) Cryptotanshinone Induces Pro-death Autophagy through JNK Signaling Mediated by Reactive Oxygen Species Generation in Lung Cancer Cells
Anti-Cancer Agents in Medicinal Chemistry Editorial: Conventional, Traditional and Alternative Therapies for Cardiovascular Disorders. Part 1: Conventional Therapy
Current Pharmaceutical Design Non Peptidic Urotensin II Antagonists: Perspectives for a New Class of Drugs
Cardiovascular & Hematological Agents in Medicinal Chemistry Migraine: Pathophysiology, Pharmacology, Treatment and Future Trends
Current Vascular Pharmacology Mesenchymal Stem Cells as Mediators of Neural Differentiation
Current Stem Cell Research & Therapy